Key result
Advanced age is linked to a ~29% lower daily warfarin dose requirement.
Why the study?
Does the required warfarin maintenance dosage decrease with increasing age in elderly patients?
Observational (n=253)
Does the required warfarin maintenance dosage decrease with increasing age in elderly patients?
Elderly patients, particularly those over 85 years, require significantly lower maintenance doses of warfarin to maintain a stable INR compared to younger patients.
Answers are grounded in this paper and cite their sources.
May warrant lower warfarin doses in patients ≥85 years; leaves open need for prospective validation before practice change.
PURPOSE: The effect of age on maintenance dosages among elderly patients with a stable International Normalized Ratio (INR) was studied. METHODS: The records of all patients monitored by an anticoagulation clinic between October 2000 and July 2002 were randomly selected for review. Data collection continued until at least 50 patients were enrolled in each of the following age groups: <75, 75-79, 80-84, and >/=85 years. To be included in the analysis, patients had to have been >50 years of age, had to have had a targeted INR of 2-3, and had to have had two consecutive INR values within the targeted range not more than 60 days apart. RESULTS: A total of 532 patient charts were reviewed, and 253 met the criteria for inclusion in the study. The mean +/- S.D. age of the patients was 80.6 +/- 7.8 years (range, 55-98 years). Atrial fibrillation or flutter was the most common indication for treatment. The mean daily warfarin dose was significantly lower with increasing age; the mean +/- S.D. daily dose for patients younger than 75 years was 4.9 +/- 2.6 mg/day, while that for patients 85 years or older was 3.5 +/- 2.6 mg/day. CONCLUSION: The warfarin dosage for maintenance therapy in elderly patients, especially those older than 75 years, appeared to be inversely related to age.
No takes yet. Share an insight, caveat, or question.
Singla et al. (2005) conducted an observational in Patients requiring warfarin with a stable INR (mostly atrial fibrillation or flutter) (n=253). Advanced age (≥85 years) vs. Younger age (<75 years) was evaluated on Mean daily warfarin dose. Advanced age was associated with a lower mean daily warfarin dose, requiring /day in patients ≥85 years compared to /day in those <75 years.
Synapse has enriched 10 related papers. Consider them for comparative context: